18 March, 2016
University of Oxford – Department of Oncology
|Salary:||£30,738 to £37,768 Grade 7 p.a.|
|Contract Type:||Contract / Temporary|
|Closes:||18th April 2016|
Department of Oncology, Radiobiology Research Institute, Churchill Hospital, Oxford
We have a new and exciting opportunity for a highly motivated and enthusiastic Postdoctoral Researcher to contribute to the research of the Radiopharmacy and Molecular Imaging Group, led by Dr Bart Cornelissen. The aim of the Group is the development of novel preclinical imaging agents for oncology.
You will undertake research into the development of a novel imaging strategy for in vivo SPECT and PET imaging of cancer. The project, which is funded by CRUK, involves the development of novel imaging probes for early detection of pancreatic cancer.
You will have a PhD in chemistry, biochemistry, molecular biology or a related science, with a strong interest in cancer biology and/or imaging. Strong experimental skills and a demonstrated ability to design and carry out laboratory studies using a range of biomedical imaging techniques are essential requirements of the role. A Home Office personal licence (PIL) would be advantageous.
This is a full-time post available for a fixed-term of 1 year in the first instance.
All applicants must complete a short application form and upload a CV and supporting statement.
The closing date for applications is 12.00 noon on 18 April 2016.
Interviews are scheduled for 4 May 2016.
This post is not valid after Sunday April 17th, 2016